Targeting NNMT significantly inhibited tumor growth and enhanced the apoptotic effects induced by anti-PD-L1 antibodies in mouse models of urothelial bladder cancer treated with the NNMT inhibitor 5-amino-1-methylquinoline iodide. This evidence concerns the gene CD274 and bladder transitional cell carcinoma.